Cargando…

The Present and Future of Prostate Cancer Urine Biomarkers

In order to successfully cure patients with prostate cancer (PCa), it is important to detect the disease at an early stage. The existing clinical biomarkers for PCa are not ideal, since they cannot specifically differentiate between those patients who should be treated immediately and those who shou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rigau, Marina, Olivan, Mireia, Garcia, Marta, Sequeiros, Tamara, Montes, Melania, Colás, Eva, Llauradó, Marta, Planas, Jacques, de Torres, Inés, Morote, Juan, Cooper, Colin, Reventós, Jaume, Clark, Jeremy, Doll, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2013
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3709804/ https://www.ncbi.nlm.nih.gov/pubmed/23774836 http://dx.doi.org/10.3390/ijms140612620

Ejemplares similares

Molecular Markers for Prostate Cancer in Formalin-Fixed Paraffin-Embedded Tissues
por: Sequeiros, Tamara, et al.
Publicado: (2013)

Simultaneous Treatment with Statins and Aspirin Reduces the Risk of Prostate Cancer Detection and Tumorigenic Properties in Prostate Cancer Cell Lines
por: Olivan, M., et al.
Publicado: (2015)

Role of Serum Cholesterol and Statin Use in the Risk of Prostate Cancer Detection and Tumor Aggressiveness
por: Morote, Juan, et al.
Publicado: (2014)

Targeted proteomics in urinary extracellular vesicles identifies biomarkers for diagnosis and prognosis of prostate cancer
por: Sequeiros, Tamara, et al.
Publicado: (2016)

Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples
por: Olivan, Mireia, et al.
Publicado: (2021)

Non-Coding RNAs in Saliva: Emerging Biomarkers for Molecular Diagnostics
por: Majem, Blanca, et al.
Publicado: (2015)

Gene-Transcript Expression in Urine Supernatant and Urine Cell-Sediment Are Different but Equally Useful for Detecting Prostate Cancer
por: Yazbek Hanna, Marcelino, et al.
Publicado: (2023)

Exosome-like vesicles in uterine aspirates: a comparison of ultracentrifugation-based isolation protocols
por: Campoy, Irene, et al.
Publicado: (2016)

Enabling Metabolomics Based Biomarker Discovery Studies Using Molecular Phenotyping of Exosome-Like Vesicles
por: Altadill, Tatiana, et al.
Publicado: (2016)

Identification, characterization and expression of novel Sex Hormone Binding Globulin alternative first exons in the human prostate
por: Pinós, Tomàs, et al.
Publicado: (2009)

Prostate Tumor Overexpressed-1 (PTOV1) promotes docetaxel-resistance and survival of castration resistant prostate cancer cells
por: Cánovas, Verónica, et al.
Publicado: (2017)

E-cadherin: A determinant molecule associated with ovarian cancer progression, dissemination and aggressiveness
por: Rosso, Marina, et al.
Publicado: (2017)

Estrogen Receptor Beta Displays Cell Cycle-Dependent Expression and Regulates the G1 Phase through a Non-Genomic Mechanism in Prostate Carcinoma Cells
por: Hurtado, Antoni, et al.
Publicado: (2008)

Bladder Cancer in an Inguinoscrotal Vesical Hernia
por: Regis, Lucas, et al.
Publicado: (2012)

Definition of Castrate Resistant Prostate Cancer: New Insights
por: Morote, Juan, et al.
Publicado: (2022)

Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review
por: Aguilar, Adriana, et al.
Publicado: (2023)

Application of One-Step Nucleic Acid Amplification (OSNA) in different cancer entities and usefulness in prostate cancer: a systematic review
por: Cuadras, Mercè, et al.
Publicado: (2022)

Improving the Early Detection of Clinically Significant Prostate Cancer in Men in the Challenging Prostate Imaging-Reporting and Data System 3 Category
por: Morote, Juan, et al.
Publicado: (2022)

Comparison of Proclarix, PSA Density and MRI-ERSPC Risk Calculator to Select Patients for Prostate Biopsy after mpMRI
por: Campistol, Miriam, et al.
Publicado: (2022)

Magnetic Resonance Imaging-Based Predictive Models for Clinically Significant Prostate Cancer: A Systematic Review
por: Triquell, Marina, et al.
Publicado: (2022)

Human SHBG mRNA Translation Is Modulated by Alternative 5′-Non-Coding Exons 1A and 1B
por: Pinós, Tomàs, et al.
Publicado: (2010)

Accuracy of serum luteinizing hormone and serum testosterone measurements to assess the efficacy of medical castration in prostate cancer patients
por: Morote, Juan, et al.
Publicado: (2017)

The Efficacy of Proclarix to Select Appropriate Candidates for Magnetic Resonance Imaging and Derived Prostate Biopsies in Men with Suspected Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Multiparametric MRI for Staging of Prostate Cancer: A Multicentric Analysis of Predictive Factors to Improve Identification of Extracapsular Extension before Radical Prostatectomy
por: Triquell, Marina, et al.
Publicado: (2022)

Editorial: Artificial intelligence: A step forward in biomarker discovery and integration towards improved cancer diagnosis and treatment
por: Vazquez-Levin, Mónica Hebe, et al.
Publicado: (2023)

A risk‐organised model for clinically significant prostate cancer early detection
por: Morote, Juan, et al.
Publicado: (2023)

Identification of early stage recurrence endometrial cancer biomarkers using bioinformatics tools
por: Besso, María josé, et al.
Publicado: (2020)

Serum Luteinizing Hormone Testing Can Identify Optimal Medical Castration
por: Morote, Juan, et al.
Publicado: (2020)

Characterization of the molecular changes associated with the overexpression of a novel epithelial cadherin splice variant mRNA in a breast cancer model using proteomics and bioinformatics approaches: identification of changes in cell metabolism and an increased expression of lactate dehydrogenase B
por: Rosso, Marina, et al.
Publicado: (2019)

Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy
por: Morote, Juan, et al.
Publicado: (2022)

Multiple immunofluorescence assay identifies upregulation of Active β-catenin in prostate cancer
por: Puig, Pere, et al.
Publicado: (2019)

Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy
por: Ulldemolins, Marta, et al.
Publicado: (2014)

Comparison of Rotterdam and Barcelona Magnetic Resonance Imaging Risk Calculators for Predicting Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2023)

The Urine Biomarker PUR-4 Is Positively Associated with the Amount of Gleason 4 in Human Prostate Cancers
por: Ball, Richard Y., et al.
Publicado: (2021)

Using gene expression from urine sediment to diagnose prostate cancer: development of a new multiplex mRNA urine test and validation of current biomarkers
por: Mengual, Lourdes, et al.
Publicado: (2016)

Development of a sequential workflow based on LC-PRM for the verification of endometrial cancer protein biomarkers in uterine aspirate samples
por: Martinez-Garcia, Elena, et al.
Publicado: (2016)

The effect of non‐absorbent hydrophobic sand litter on the urine protein‐to‐creatinine ratio in feline urine
por: Kennils, Josh M., et al.
Publicado: (2022)

The Barcelona Predictive Model of Clinically Significant Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Light Intensity Alters the Behavior of Monilinia spp. in vitro and the Disease Development on Stone Fruit-Pathogen Interaction
por: Balsells-Llauradó, Marta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_stu9v61c2s2cek1i57b6pld300